117 related articles for article (PubMed ID: 22948360)
1. Synergistic increase in the sensitivity of osteosarcoma cells to thermochemotherapy with combination of paclitaxel and etoposide.
Huang T; Gong WH; Li XC; Zou CP; Jiang GJ; Li XH; Feng DP
Mol Med Rep; 2012 Nov; 6(5):1013-7. PubMed ID: 22948360
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by a combination of paclitaxel and carboplatin in the presence of hyperthermia.
Huang T; Gong WH; Li XC; Zou CP; Jiang GJ; Li XH; Feng DP
Asian Pac J Cancer Prev; 2012; 13(1):81-5. PubMed ID: 22502718
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of osteosarcoma cell sensitivity to cisplatin using paclitaxel in the presence of hyperthermia.
Huang T; Gong W; Li X; Zou C; Jiang G; Li X; Feng D
Int J Hyperthermia; 2013 May; 29(3):248-55. PubMed ID: 23527624
[TBL] [Abstract][Full Text] [Related]
4. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
[TBL] [Abstract][Full Text] [Related]
6. Efficient killing effect of osteosarcoma cells by cinobufacini and cisplatin in combination.
Huang T; Gong WH; Li XC; Zou CP; Jiang GJ; Li XH; Qian H
Asian Pac J Cancer Prev; 2012; 13(6):2847-51. PubMed ID: 22938471
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel and etoposide-loaded Poly (lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for dual drug delivery.
Zhang M; Tang Y; Zhu Z; Zhao H; Yao J; Sun D
J Biomater Sci Polym Ed; 2018 Nov; 29(16):1949-1963. PubMed ID: 29920151
[TBL] [Abstract][Full Text] [Related]
8. [p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide].
Zhu JJ; Liao WM; Li FB; Zhu XF; Zhou JM; Liu ZC
Ai Zheng; 2004 Jun; 23(6):640-4. PubMed ID: 15191662
[TBL] [Abstract][Full Text] [Related]
9. Synergistic apoptotic effect of crocin and cisplatin on osteosarcoma cells via caspase induced apoptosis.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Toxicol Lett; 2013 Aug; 221(3):197-204. PubMed ID: 23830991
[TBL] [Abstract][Full Text] [Related]
10. Polymer-lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma.
Duan R; Li C; Wang F; Yangi JC
Colloids Surf B Biointerfaces; 2017 Nov; 159():880-887. PubMed ID: 28892872
[TBL] [Abstract][Full Text] [Related]
11. The Poly(ADP-ribose) polymerase-1-regulated endonuclease DNAS1L3 is required for etoposide-induced internucleosomal DNA fragmentation and increases etoposide cytotoxicity in transfected osteosarcoma cells.
Boulares AH; Zoltoski AJ; Sherif ZA; Yakovlev AG; Smulson ME
Cancer Res; 2002 Aug; 62(15):4439-44. PubMed ID: 12154052
[TBL] [Abstract][Full Text] [Related]
12. Blocking miR-27a-3p sensitises Taxol resistant osteosarcoma cells through targeting Fbxw7.
Lu B; Feng Z; Fan B; Shi Y
Bull Cancer; 2021 Jun; 108(6):596-604. PubMed ID: 33863546
[TBL] [Abstract][Full Text] [Related]
13. Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells.
Kim HJ; Lee SG; Kim YJ; Park JE; Lee KY; Yoo YH; Kim JM
Int J Oncol; 2013 Jun; 42(6):1985-92. PubMed ID: 23563171
[TBL] [Abstract][Full Text] [Related]
14. Role of heat treatment in childhood cancers: distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy.
Debes A; Willers R; Göbel U; Wessalowski R
Pediatr Blood Cancer; 2005 Oct; 45(5):663-9. PubMed ID: 15929134
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
16. Paxilitaxel induces apoptosis accompanied by protective autophagy in osteosarcoma cells through hypoxia-inducible factor-1α pathway.
Guo Y; Huang C; Li G; Chen T; Li J; Huang Z
Mol Med Rep; 2015 Sep; 12(3):3681-3687. PubMed ID: 26017247
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma.
Worth LL; Jaffe N; Benjamin RS; Papadopoulos NE; Patel S; Raymond AK; Jia SF; Rodriguez C; Gano J; Gianan MA; Kleinerman ES
Clin Cancer Res; 1997 Oct; 3(10):1721-9. PubMed ID: 9815556
[TBL] [Abstract][Full Text] [Related]
18. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
Maschek G; Savaraj N; Priebe W; Braunschweiger P; Hamilton K; Tidmarsh GF; De Young LR; Lampidis TJ
Cancer Res; 2004 Jan; 64(1):31-4. PubMed ID: 14729604
[TBL] [Abstract][Full Text] [Related]
19. Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell lines.
Perez EA; Buckwalter CA
Cancer Chemother Pharmacol; 1998; 41(6):448-52. PubMed ID: 9554587
[TBL] [Abstract][Full Text] [Related]
20. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.
Ong SM; Saeki K; Tanaka Y; Nishimura R; Nakagawa T
Vet J; 2016 Dec; 218():51-59. PubMed ID: 27938709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
